Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV gene therapy using RNA virus systems.

Masaaki Hayafune1, Naoko Miyano-Kurosaki, Akiko Kusunoki

  • 1Department of Life and Environmental Science, Chiba Institute of Technology, 2-17-1 Tsudanuma, Narashino, Chiba 275-0016, Japan.

Nucleic Acids Symposium Series (2004)
|December 8, 2006
PubMed
Summary

Researchers developed a novel DNAzyme expression vector using HIV-1 reverse transcription. This vector effectively suppressed HIV-1 replication in cell cultures, offering a potential new therapeutic strategy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Prolonged Treatment with Pemafibrate plus an HMG-CoA Reductase Inhibitor in Japanese Patients with Type 2 Diabetes Mellitus.

Drug research·2025
Same author

Effects of SGLT2 Inhibitors and DPP-4 Inhibitors on Advanced Glycation End Products.

Drug research·2024
Same author

Effects of SGLT2 inhibitors on the intestinal bacterial flora in Japanese patients with type 2 diabetes mellitus.

Drug research·2023
Same author

Recombinant baculovirus expressing the FrC-OVA protein induces protective antitumor immunity in an EG7-OVA mouse model.

Journal of biological engineering·2019
Same author

A 30-year record reveals re-equilibration rates of <sup>137</sup>Cs in marine biota after the Fukushima Dai-ichi nuclear power plant accident: Concentration ratios in pre- and post-event conditions.

The Science of the total environment·2019
Same author

Contribution of Three Different Regions of Isocitrate Dehydrogenases from Psychrophilic and Psychrotolerant Bacteria to Their Thermal Properties.

Current microbiology·2018

Area of Science:

  • Molecular Biology
  • Virology
  • Biotechnology

Background:

  • Human Immunodeficiency Virus type 1 (HIV-1) replication is a complex process dependent on viral enzymes and RNA structures.
  • Targeting specific viral components, such as the HIV-1 env V3 loop, is a key strategy in developing antiviral therapies.
  • DNAzymes offer catalytic activity and can be engineered for specific molecular targets.

Purpose of the Study:

  • To design and construct a novel DNAzyme expression vector.
  • To utilize HIV-1 reverse transcription for the synthesis of single-stranded DNA (ssDNA).
  • To evaluate the efficacy of the DNAzyme against the HIV-1 env V3 loop in suppressing viral replication.

Main Methods:

  • Development of a lentiviral expression vector engineered with HIV-1 primer binding site (PBS) and tRNALys.

Related Experiment Videos

  • Utilizing HIV-1 reverse transcriptase for the synthesis of ssDNA from the vector's RNA transcript.
  • Transduction of SupT1 cells with the lentiviral vector expressing the DNAzyme.
  • Assessment of HIV-1 replication suppression in transduced cells.

    • Main Results:

    • The engineered vector successfully produced ssDNA via HIV-1 reverse transcription.
    • The expressed DNAzyme demonstrated the ability to target the HIV-1 env V3 loop.
    • Significant suppression of HIV-1 replication was observed in SupT1 cells transduced with the DNAzyme-expressing lentiviral vector.

    Conclusions:

    • The developed DNAzyme expression vector is a viable tool for producing functional DNAzymes.
    • This approach effectively leverages HIV-1 reverse transcription machinery for therapeutic molecule synthesis.
    • The DNAzyme demonstrated potent anti-HIV-1 activity, suggesting potential as a novel therapeutic intervention.